View Item 

Show simple item record

Assessment of the biodistribution of an [ 18 F]FDG‐loaded perfluorocarbon double emulsion using dynamic micro‐PET in rats

dc.contributor.authorFabiilli, Mario L.en_US
dc.contributor.authorPiert, Morand R.en_US
dc.contributor.authorKoeppe, Robert A.en_US
dc.contributor.authorSherman, Phillip S.en_US
dc.contributor.authorQuesada, Carole A.en_US
dc.contributor.authorKripfgans, Oliver D.en_US
dc.date.accessioned2013-05-02T19:35:16Z
dc.date.available2014-09-02T14:12:52Zen_US
dc.date.issued2013-07en_US
dc.identifier.citationFabiilli, Mario L.; Piert, Morand R.; Koeppe, Robert A.; Sherman, Phillip S.; Quesada, Carole A.; Kripfgans, Oliver D. (2013). "Assessment of the biodistribution of an [ 18 F]FDG‐loaded perfluorocarbon double emulsion using dynamic micro‐PET in rats." Contrast Media & Molecular Imaging 8(4): 366-374. <http://hdl.handle.net/2027.42/97497>en_US
dc.identifier.issn1555-4309en_US
dc.identifier.issn1555-4317en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/97497
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherMicro‐PETen_US
dc.subject.otherResponsive Agentsen_US
dc.subject.otherUltrasounden_US
dc.subject.otherAcoustic Droplet Vaporizationen_US
dc.subject.otherEmulsionen_US
dc.subject.otherPerfluorocarbonen_US
dc.subject.otherBiodistributionen_US
dc.titleAssessment of the biodistribution of an [ 18 F]FDG‐loaded perfluorocarbon double emulsion using dynamic micro‐PET in ratsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid23613440en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/97497/1/cmmi1532.pdf
dc.identifier.doi10.1002/cmmi.1532en_US
dc.identifier.sourceContrast Media & Molecular Imagingen_US
dc.identifier.citedreferenceSatterfield R, Tarter VM, Schumacher DJ, Tran P, Mattrey RF. Comparison of different perfluorocarbons as ultrasound contrast agents. Invest Radiol 1993; 28 ( 4 ): 325 – 331.en_US
dc.identifier.citedreferenceRapoport N, Gao Z, Kennedy A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst 2007; 99 ( 14 ): 1095 – 1106.en_US
dc.identifier.citedreferenceKripfgans OD, Fowlkes JB, Woydt M, Eldevik OP, Carson PL. In vivo droplet vaporization for occlusion therapy and phase aberration correction. IEEE Trans Ultrason Ferroelectr Freq Control 2002; 49 ( 2 ): 726 – 738.en_US
dc.identifier.citedreferenceKripfgans OD, Orifici CM, Carson PL, Ives KA, Eldevik OP, Fowlkes JB. Acoustic droplet vaporization for temporal and spatial control of tissue occlusion: a kidney study. IEEE Trans Ultrason Ferroelectr Freq Control 2005; 52 ( 7 ): 1101 – 1110.en_US
dc.identifier.citedreferenceZhang M, Fabiilli ML, Haworth KJ, Fowlkes JB, Kripfgans OD, Roberts WW, Ives KA, Carson PL. Initial investigation of acoustic droplet vaporization for occlusion in canine kidney. Ultrasound Med Biol 2010; 36 ( 10 ): 1691 – 1703.en_US
dc.identifier.citedreferenceHaworth KJ, Fowlkes JB, Carson PL, Kripfgans OD. Towards aberration correction of transcranial ultrasound using acoustic droplet vaporization. Ultrasound Med Biol 2008; 34 ( 3 ): 435 – 445.en_US
dc.identifier.citedreferenceBentley PK, Johnson OL, Washington C, Lowe KC. Uptake of concentrated perfluorocarbon emulsions into rat lymphoid‐tissues. J Pharm Pharmacol 1993; 45 ( 3 ): 182 – 185.en_US
dc.identifier.citedreferenceRiess JG. Oxygen carriers ('blood substitutes’) – raison d'etre, chemistry, and some physiology. Chem Rev 2001; 101 ( 9 ): 2797 – 2919.en_US
dc.identifier.citedreferenceCouture O, Urban A, Bretagne A, Martinez L, Tanter M, Tabeling P. In vivo targeted delivery of large payloads with an ultrasound clinical scanner. Med Phys 2012; 39 ( 8 ): 5229 – 5237.en_US
dc.identifier.citedreferenceLanza GM, Wallace KD, Scott MJ, Cacheris WP, Abendschein DR, Christy DH, Sharkley AM, Miller JG, Gaffney PJ, Wickline SA. A novel site‐targeted ultrasonic contrast agent with broad biomedical application. Circulation 1996; 94 ( 12 ): 3334 – 3340.en_US
dc.identifier.citedreferenceGanta S, Paxton JW, Baguley BC, Garg S. Pharmacokinetics and pharmacodynamics of chlorambucil delivered in parenteral emulsion. Int J Pharm 2008; 360 ( 1–2 ): 115 – 121.en_US
dc.identifier.citedreferenceApfel RE. Superheated drop detector. Nucl Instrum Meth 1979; 162 ( 1–3 ): 603 – 608.en_US
dc.identifier.citedreferenced'Errico F. Radiation dosimetry and spectrometry with superheated emulsions. Nucl Instrum Meth Phys Res B 2001; 184: 229 – 254.en_US
dc.identifier.citedreferenceFicheux MF, Bonakdar L, Leal‐Calderon F, Bibette J. Some stability criteria for double emulsions. Langmuir 1998; 14 ( 10 ): 2702 – 2706.en_US
dc.identifier.citedreferenceWest CML, Jones T, Price P. The potential of positron‐emission tomography to study anticancer‐drug resistance. Nat Rev Cancer 2004; 4 ( 6 ): 457 – 469.en_US
dc.identifier.citedreferenceToyama H, Ichise M, Liow JS, Vines DC, Seneca NM, Modell KJ, Seidel J, Green MV, Innis RB. Evaluation of anesthesia effects on [F‐18]FDG uptake in mouse brain and heart using small animal PET. Nucl Med Biol 2004; 31 ( 2 ): 251 – 256.en_US
dc.identifier.citedreferenceFueger BJ, Czernin J, Hildebrandt I, Tran C, Halpern BS, Stout D, Phelps ME, Weber WA. Impact of animal handling on the results of F‐18‐FDG PET studies in mice. J Nucl Med 2006; 47 ( 6 ): 999 – 1006.en_US
dc.identifier.citedreferenceCanaud B, Aljama P, Tielemans C, Gasparovic V, Gutierrez A, Locatelli F. Pathochemical toxicity of perfluorocarbon‐5070, a liquid test performance fluid previously used in dialyzer manufacturing, confirmed in animal experiment. J Am Soc Nephrol 2005; 16 ( 6 ): 1819 – 1823.en_US
dc.identifier.citedreferenceKutscher HL, Chao P, Deshmukh M, Singh Y, Hu P, Joseph LB, Reimer DC, Stein S, Laskin DL, Sinko PJ. Threshold size for optimal passive pulmonary targeting and retention of rigid microparticles in rats. J Control Release 2010; 143 ( 1 ): 31 – 37.en_US
dc.identifier.citedreferenceSchwinn DA, Mcintyre RW, Reves JG. Isoflurane‐induced vasodilation – role of the alpha‐adrenergic nervous‐system. Anesth Analg 1990; 71 ( 5 ): 451 – 459.en_US
dc.identifier.citedreferenceOwens DE, Peppas NA. Opsonization, biodistribution, and pharmaokinetics of polymeric nanoparticles. Int J Pharm 2006; 307 ( 1 ): 93 – 102.en_US
dc.identifier.citedreferenceGiraudeau C, Djemai B, Ghaly MA, Boumezbeur F, Meriaux S, Robert P, Port M, Robic C, Le Bihan D, Lethimonnier F, Valette J. High sensitivity 19F MRI of a perfluorooctyl bromide emulsion: application to a dynamic biodistribution study and oxygen tension mapping in the mouse liver and spleen. NMR Biomed 2012; 25 ( 4 ): 654 – 660.en_US
dc.identifier.citedreferenceTroster SD, Muller U, Kreuter J. Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants. Int J Pharm 1990; 61 ( 1–2 ): 85 – 100.en_US
dc.identifier.citedreferenceVittaz M, Bazile D, Spenlehauer G, Verrecchia T, Veillard M, Puisieux F, Labarre D. Effect of PEO surface density on long‐circulating PLA‐PEO nanoparticles which are very low complement activators. Biomaterials 1996; 17 ( 16 ): 1575 – 1581.en_US
dc.identifier.citedreferenceKnoess C, Siegel S, Smith A, Newport D, Richerzhagen N, Winkeler A, Jacobs A, Goble RN, Graf R, Wienhard K, Heiss WD. Performance evaluation of the microPET R4 PET scanner for rodents. Eur J Nucl Med Mol Imag 2003; 30 ( 5 ): 737 – 747.en_US
dc.identifier.citedreferenceFerrara KW, Pollard R, Borden MA. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng 2007; 9: 425 – 447.en_US
dc.identifier.citedreferenceMiller DL, Averkiou MA, Brayman AA, Everbach EC, Holland CK, Wible JH, Wu J. Bioeffects considerations for diagnostic ultrasound contrast agents. J Ultrasound Med 2008; 27 ( 4 ): 611 – 632.en_US
dc.identifier.citedreferencePillai R, Marinelli ER, Fan H, Nanjappan P, Song B, von Wronski MA, Cherkaoui S, Tardy I, Pochon S, Schneider M, Nunn AD, Swenson RE. A phospholipid‐PEG2000 conjugate of a vascular endothelial growth factor receptor 2 (VEGFR2)‐targeting heterodimer peptide for contrast‐enhanced ultrasound imaging of angiogenesis. Bioconjug Chem 2010; 21 ( 3 ): 556 – 562.en_US
dc.identifier.citedreferenceBzyl J, Lederle W, Rix A, Grouls C, Tardy I, Pochon S, Siepmann M, Penzkofer T, Schneider M, Kiessling F, Palmowski M. Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38). Eur Radiol 2011; 21 ( 9 ): 1988 – 1995.en_US
dc.identifier.citedreferenceDatta S, Coussios CC, Ammi AY, Mast TD, de Courten‐Myers GM, Holland CK. Ultrasound‐enhanced thrombolysis using Definity as a cavitation nucleation agent. Ultrasound Med Biol 2008; 34 ( 9 ): 1421 – 1433.en_US
dc.identifier.citedreferenceWatanabe Y, Horie S, Funaki Y, Kikuchi Y, Yamazaki H, Ishii K, Mori S, Vassaux G, Kodama T. Delivery of Na/I symporter gene into skeletal muscle using nanobubbles and ultrasound: visualization of gene expression by PET. J Nucl Med 2010; 51 ( 6 ): 951 – 958.en_US
dc.identifier.citedreferenceTartis MS, McCallan J, Lum AFH, LaBell R, Stieger SM, Matsunaga TO, Ferrara KW. Therapeutic effects of paclitaxel‐containing ultrasound contrast agents. Ultrasound Med Biol 2006; 32 ( 11 ): 1771 – 1780.en_US
dc.identifier.citedreferenceCerroni B, Chiessi E, Margheritelli S, Oddo L, Paradossi G. Polymer shelled microparticles for a targeted doxorubicin delivery in cancer therapy. Biomacromolecules 2011; 12 ( 3 ): 593 – 601.en_US
dc.identifier.citedreferenceYu TH, Fan XL, Xiong SH, Hu K, Wang ZB. Microbubbles assist goat liver ablation by high intensity focused ultrasound. Eur Radiol 2006; 16 ( 7 ): 1557 – 1563.en_US
dc.identifier.citedreferenceDiaz‐Lopez R, Tsapis N, Fattal E. Liquid perfluorocarbons as contrast agents for ultrasonography and 19F‐MRI. Pharm Res 2010; 27 ( 1 ): 1 – 16.en_US
dc.identifier.citedreferenceFabiilli ML, Haworth KJ, Sebastian IE, Kripfgans OD, Carson PL, Fowlkes JB. Delivery of chlorambucil using an acoustically‐triggered perfluoropentane emulsion. Ultrasound Med Biol 2010; 36 ( 8 ): 1364 – 1375.en_US
dc.identifier.citedreferenceHwang TL, Lin YJ, Chi CH, Huang TH, Fang JY. Development and evaluation of perfluorocarbon nanobubbles for apomorphine delivery. J Pharmacol Sci 2009; 98 ( 10 ): 3735 – 3747.en_US
dc.identifier.citedreferenceRapoport NY, Kennedy AM, Shea JE, Scaife CL, Nam K‐H. Controlled and targeted tumor chemotherapy by ultrasound‐activated nanoemulsions/microbubbles. J Control Release 2009; 138 ( 2 ): 268 – 276.en_US
dc.identifier.citedreferenceWang CH, Kang ST, Lee YH, Luo YL, Huang YF, Yeh CK. Aptamer‐conjugated and drug‐loaded acoustic droplets for ultrasound theranosis. Biomaterials 2012; 33 ( 6 ): 1939 – 1947.en_US
dc.identifier.citedreferenceZhang M, Fabiilli ML, Haworth KJ, Padilla F, Swanson SD, Kripfgans OD, Carson PL, Fowlkes JB. Acoustic droplet vaporization for enhancement of thermal ablation by high intensity focused ultrasound. Acad Radiol 2011; 18 ( 9 ): 1123 – 1132.en_US
dc.identifier.citedreferenceZhang P, Porter T. An in vitro study of a phase‐shift nanoemulsion: a potential nucleation agent for bubble‐enhanced hifu tumor ablation. Ultrasound Med Biol 2010; 36 ( 11 ): 1856 – 1866.en_US
dc.identifier.citedreferencede Jong N, ten Cate FJ, Vletter WB, Roelandt JRTC. Quantification of transpulmonary echocontrast effects. Ultrasound Med Biol 1993; 19 ( 4 ): 279 – 288.en_US
dc.identifier.citedreferenceLeakakos T, Schutt EG, Calvin JC, Smith D, Bradley JD, Strnat CA, del Balzo U, Hazard DY, Otto S, Fields TK, Keipert PE, Klein DH, Flaim SF. Pulmonary gas trapping differences among animal species in response to intravenous infusion of perfluorocarbon emulsions. Artif Cell Blood Sub 1994; 22 ( 4 ): 1199 – 1204.en_US
dc.identifier.citedreferenceSchutt E, Barber P, Fields T, Flaim S, Horodniak J, Keipert P, Kinner R, Kornburst L, Leakakos T, Pelura T, Weers J, Houmes R, Lachmann B. Proposed mechanism of pulmonary gas trapping (PGT) following intravenous perfluorocarbon emulsion administration. Artif Cell Blood Sub 1994; 22 ( 4 ): 1205 – 1214.en_US
dc.identifier.citedreferenceRapoport N, Nam KH, Gupta R, Gao ZG, Mohan P, Payne A, Todd N, Liu X, Kim T, Shea J, Scaife C, Parker DL, Jeong EK, Kennedy AM. Ultrasound‐mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions. J Control Release 2011; 153 ( 1 ): 4 – 15.en_US
dc.identifier.citedreferenceWillmann JK, Cheng Z, Davis C, Lutz AM, Schipper MK, Nielsen CH, Gambhir SS. Targeted microbubbles for imaging tumor angiogenesis: assessment of whole‐body biodistribution with dynamic micro‐PET in mice. Radiology 2008; 249 ( 1 ): 212 – 219.en_US
dc.identifier.citedreferencePerkins AC, Frier M, Hindle AJ, Blackshaw PE, Bailey SE, Hebden JM, Middleton SM, Wastie ML. Human biodistribution of an ultrasound contrast agent (Quantison(TM)) by radiolabelling and gamma scintigraphy. Br J Radiol 1997; 70 ( 834 ): 603 – 611.en_US
dc.identifier.citedreferenceFerrara KW, Borden MA, Zhang H. Lipid‐shelled vehicles: engineering for ultrasound molecular imaging and drug delivery. Acc Chem Res 2009; 42 ( 7 ): 881 – 892.en_US
dc.identifier.citedreferenceTartis MS, Kruse DE, Zheng HR, Zhang H, Kheirolomoom A, Marik J, Ferrara KW. Dynamic microPET imaging of ultrasound contrast agents and lipid delivery. J Control Release 2008; 131 ( 3 ): 160 – 166.en_US
dc.identifier.citedreferenceKok MB, de Vries A, Abdurrachim D, Prompers JJ, Grull H, Nicolay K, Strijkers GJ. Quantitative H‐1 MRI, F‐19 MRI, and F‐19 MRS of cell‐internalized perfluorocarbon paramagnetic nanoparticles. Contrast Media Mol I 2011; 6 ( 1 ): 19 – 27.en_US
dc.identifier.citedreferenceMohan P, Rapoport N. Doxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound‐mediated intracellular delivery and nuclear trafficking. Mol Pharm 2010; 7 ( 6 ): 1959 – 1973.en_US
dc.identifier.citedreferenceGorelikov I, Martin AL, Seo M, Matsuura N. Silica‐coated quantum dots for optical evaluation of perfluorocarbon droplet interactions with cells. Langmuir 2011; 27 ( 24 ): 15024 – 15033.en_US
dc.identifier.citedreferenceAnderson CR, Hu XW, Zhang H, Tlaxca J, Decleves AE, Houghtaling R, Sharma K, Lawrence M, Ferrara KW, Rychak JJ. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent. Invest Radiol 2011; 46 ( 4 ): 215 – 224.en_US
dc.identifier.citedreferencePiroth MD, Pinkawa M, Holy R, Klotz J, Nussen S, Stoffels G, Coenen HH, Kaiser HJ, Langen KJ, Eble MJ. Prognostic value of early [(18)F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme. Int J Radiat Oncol 2011; 80 ( 1 ): 176 – 184.en_US
dc.identifier.citedreferenceBasu S Personalized versus evidence‐based medicine with PET‐based imaging. Nat Rev Clin Oncol 2010; 7 ( 11 ): 665 – 668.en_US
dc.identifier.citedreferenceFabiilli ML, Lee JA, Kripfgans OD, Carson PL, Fowlkes JB. Delivery of water‐soluble drugs using acoustically triggered perfluorocarbon double emulsions. Pharm Res 2010; 27 ( 12 ): 2753 – 2765.en_US
dc.identifier.citedreferenceRajian JR, Fabiilli ML, Fowlkes JB, Carson PL, Wang X. Drug delivery monitoring by photoacoustic tomography with an ICG encapsulated double emulsion. Opt Express 2011; 19 ( 15 ): 14335 – 14347.en_US
dc.identifier.citedreferenceCouture O, Faivre M, Pannacci N, Babataheri A, Servois V, Tabeling P, Tanter M. Ultrasound internal tattooing. Med Phys 2011; 38 ( 2 ): 1116 – 1123.en_US
dc.identifier.citedreferenceApfel RE, Apfel Enterprises Inc., assignee. Activatable infusable dispersions containing drops of a superheated liquid for methods of therapy and diagnosis. United States Patent, November 1998.en_US
dc.identifier.citedreferenceKripfgans OD, Fowlkes JB, Miller DL, Eldevik OP, Carson PL. Acoustic droplet vaporization for therapeutic and diagnostic applications. Ultrasound Med Biol 2000; 26 ( 7 ): 1177 – 1189.en_US
dc.identifier.citedreferenceSheeran PS, Luois S, Dayton PA, Matsunaga TO. Formulation and acoustic studies of a new phase‐shift agent for diagnostic and therapeutic ultrasound. Langmuir 2011; 27 ( 17 ): 10412 – 10420.en_US
dc.identifier.citedreferenceMartz TD, Sheeran PS, Bardin D, Lee AP, Dayton PA. Precision manufacture of phase‐change perfluorocarbon droplets using microfluidics. Ultrasound Med Biol 2011; 37 ( 11 ): 1952 – 1957.en_US
dc.identifier.citedreferenceFabiilli ML, Haworth KJ, Fakhri NH, Kripfgans OD, Carson PL, Fowlkes JB. The role of inertial cavitation in acoustic droplet vaporization. IEEE Trans Ultrason Ferroelectr Freq Control 2009; 56 ( 5 ): 1006 – 1017.en_US
dc.identifier.citedreferenceFang JY, Hung CF, Hua SC, Hwang TL. Acoustically active pefluorocarbon nanoemulsions as drug delivery carriers for camptothecin: drug release and cytoxicity against cancer cells. Ultrasonics 2009; 49 ( 1 ): 39 – 46.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cmmi1532.pdf
Size:
342.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.